Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy. In this long-term follow-up registry we plan to collect data on clinical status, standard laboratory results including lipidogram values, NTproBNP values after specific interventions (in.ex. TAVI implantation, SGLT2inh prescripition), bleeding complications, and every major cardiovascular event, including cardiovascular death and all cause death.
Study Type
OBSERVATIONAL
Enrollment
3,000
long-term follow up and observation of patients treated in Cardiology department in the tertiary center and University hospital
Dubrava University Hospital
Zagreb, Croatia
RECRUITINGcardiovascular death
death due to cardiovascular etiology during long term follow-up
Time frame: 10 years
freedom from atrial arrhythmias
Freedom from atrial arrhythmias after PVI during mid-term folow-up (1 year) and long-term follow-up
Time frame: 10 years
Time to revascularization
Time to revascularization during acute coronary syndrome
Time frame: 10 years
Bleeding complications
Bleeding complications during long-term follow-up in patients prescribed with oral anticoagulation and/or antithrombotic therapy
Time frame: 10 years
Laboratory levels of NTproBNP
Laboratory levels of NTproBNP in patients with AFib after PVI, in patients with HF prescribed with SGLT2 inhibitors, in patients with ACS after complete revasculariazation, in patients implanted with CIED
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.